Nektar TherapeuticsNKTRNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank0
3Y CAGR-15.7%
5Y CAGR-18.4%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
-15.7%/yr
vs -47.3%/yr prior
5Y CAGR
-18.4%/yr
Consistent
Acceleration
+31.6pp
Accelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$55.23M-43.9%
2024$98.43M+9.2%
2023$90.12M-2.1%
2022$92.06M-9.7%
2021$101.91M-33.4%
2020$152.91M+33.4%
2019$114.62M-90.4%
2018$1.19B+287.8%
2017$307.71M+86.0%
2016$165.44M-